Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants

Blood

Volumn 102, Issue 4, 2003, Pages 1534-1540

  Broers, Annoek E C ^b   Posthumus Van Sluijs, Sandra J ^b   Spits, Hergen ^b   Van der Holt, Bronno ^b   Löwenberg, Bob ^b   Braakman, Eric ^b   Cornelissen, Jan J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; RECOMBINANT INTERLEUKIN 7; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CELL MATURATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DRUG EFFECT; FLOW CYTOMETRY; IMMUNE DEFICIENCY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; THYMUS;

EID: 0042738795     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-11-3349     Document Type: Article

References (56)

1. Storek J, Witherspoon RP. Immunological reconstitution after hemopoietic stem cell transplantation, In: Atkinson K, ed. Clinical Bone Marrow and Blood Stem Cell Transplantation: A Reference Textbook. 2nd ed. Cambridge, United Kingdom: Cambridge University Press; 2000:111-146.
2. + selected grafts with recipients of unmanipulated grafts. Exp Hematol. 1999;27:561-568.
3. + selected PBPC grafts, unselected PBPC grafts or BM grafts. Bone Marrow Transplant. 1999;24:295-302.
4. Storek J, Dawson MA, Storer B, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. BJood 2001;97:3380-3389.
5. Weinberg K, Annett G, Kashyap A, Lenarsky C, Forman SJ, Parkman R. The effect of thymic function on immunocompetence following bone marrow transplantation. Biol Blood Marrow Transplant. 1995;1:18-23.
6. Small TN, Papadopoulos EB, BouJad F, et al. Comparison of immune reconstitution after unrelated and related T-cell depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood. 1999;93:467-480.
7. Roux E, Dumont-Girard F, Starobinski M, et al. Recovery of immune reactivity after T-cell depleted bone marrow transplantation depends on thymic activity. Blood. 2000;96:2299-2303.
8. Weinberg K, Blazar BR, Wagner JE, et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood. 2001;97: 1458-1466.
9. Tough DF, Sprent J. Turnover of naive- and memory-phenotype T-cells. J Exp Med. 1994; 179:1127-1135.
10. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during treatment of HIV infection. Nature. 1998;396:690-695.
11. Douek DC, Vesico RA, Betts MR, et al. Assessment of thymic output in adults after haematopoietic stem cell transplantation and prediction of T-cell reconstitution. Lancet. 2000;355:1875-1881.
12. Kong F, Chen CH, Cooper MD. Thymic function can be accurately monitored by the level of recent T-cell emigrants in the circulation. Immunity. 1998;8:97-104.
13. Hazenberg MD, Otto SA, Cohen Stuart JW, et al. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T-cell population in HIV-1 infection. Nat Med. 2000;6:1036-1042.
14. Hazenberg MD, Verschuren MCM, Hamann D, Miedema F, Van Dongen JJM. T-cell receptor excision circles (TRECs) as markers for recent thymic emigrants. Basic aspects, technical approach, and guidelines for interpretation. J Mol Med. 2001;79:631-640.
15. Lewin SR, Heller G, Zhang L, et al. Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. Blood. 2002;100:2235-2242.
16. Hochberg EP, Chillemi AC, Wu CJ, et al. Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. Blood. 2001;98:1116-1121.
17. Broers AEC, Meijerink JPP, Van Dongen JJM, et al. Quantification of newly developed T-cells in mice by real-time quantitative PCR of T-cell receptor rearrangement excision circles. Exp Hematol. 2002;30:745-750.
18. Sempowski GD, Gooding ME, Liao HX, Le PT, Haynes BF. T-cell receptor excision circle assessment of thymopoiesis in aging mice. Mol Immunol. 2002;38:841-848.
19. Fry TJ, Mackall CL. Interleukin-7: from bench to clinic. Blood. 2002;99:3892-3904.
20. Spits H. Interleukin-7. In: Oppenheim JJ, Feldman R, eds. Cytokine Reference. London, United Kingdom: Academic Press; 2001:137-154.
21. Peschon JJ, Morrissey PJ, Grabstein KH, et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med. 1994;180:1955-1960.
22. Von Freeden-Jeffry U, Vieira P, Lucian LA, McNeill T, Burdach SE, Murray R. Lymphopenia in interleukin (IL-7)-gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med. 1995;181:1519-1526.
23. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet. 1998; 20:394-397.
24. Tan JT, Dudl E, LeRoy E, et al. IL-7 is critical for homeostatic proliferation and survival of naive T-cells. Proc Natl Acad Sci U S A. 2001;98:8732-8737.
25. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T-cells in vivo. Nat Immunol. 2000;1:426-432.
26. Fry TJ, Connick E, Falloon J, et al. A potential role for interleukin-7 in T-cell homeostatasis. Blood. 2001;97:2983-2990.
27. Abdul-Hai A, Or R, Slavin S, et al. Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. Exp Hematol. 1996;24:1416-1422.
28. Bolotin E, Smogorzewska M, Smith S, Widmer M, Weinberg K. Enhancement of thymopoiesis after bone marrow transplantation by in vivo interleukin-7. Blood. 1996;88:1887-1894.
29. Levy RB, Jones M, Hamilton BL, Paupe J, Horowitz T, Riley R. IL-7 drives donor T-cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation. J Immunol. 1995;154:106-115.
30. Alpdogan O, Schmaltz C, Muriglan SJ, et al. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood. 2001;98:2256-2265.
31. Mackall CL, Fry TJ, Bare C, Morgan P, Galbraith A, Gress RE. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood. 2001; 97:1491-1497.
32. Fry TJ, Moniuszko M, Creekmore S, et al. IL-7 therapy dramatically alters peripheral T cell homeostasis in normal and SIV infected non-human primates. Blood. 2003;101:2294-2299.
33. Storek J, Gillespy T III, Lu H, et al. Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys. Blood. 2003;101:4209-4218.
34. Cobbold S, Martin G, Waldmann H. Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T-cell subsets in vitro and in vivo. Transplantation. 1986;42:239-247.
35. Storek J, Gooley T, Witherspoon RP, Sullivan KM, Storb R. Infectious morbidity in long-term survivors of allogenic marrow transplantation is associated with low CD4 T-cell counts. Am J Hematol. 1997;54:131-138.
36. Gratama JW, Van Esser JW, Lamers CH, et al. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood. 2001;98:1358-1364.
37. Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE. Thymic-independent T-cell regeneration occurs via antigen-driven expansion of peripheral T-cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol. 1996;156:4609-4616.
38. Fry TJ, Christensen BL, Komschlies KL, Gress RE, Mackall CL. Interleukin-7 restores immunity in athymic T-cell-depleted hosts. Blood. 2001;97: 1525-1533.
39. Gringhuis SI, de Leij LF, Verschuren EW, Borger P, Vellenga E. Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T-cells and activator protein-1. Blood. 1997;90:2690-2700.
40. Mehrotra PT, Grant AJ, Siegel JP. Synergistic effects of IL-7 and IL-12 on human T-cell activiation. J Immunol. 1995;154:5093-5102.
41. Borger P, Kauffman HF, Postma DS, Vellenga E. IL-7 differentially modulates the expression of IFN-gamma and IL-4 in activated human T lymphocytes by transcriptional and post-transcriptional mechanisms. J Immunol. 1996;156:1333-1338.
42. Lynch DH, Namen AE, Miller RE. In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes. Eur J Immunol. 1991;21:2977-2985.
43. Wiryana P, Bui T, Faltynek CR, Ho RJ. Augmentation of cell-mediated immunotherapy against herpes simplex virus by interleukins: comparison of in vivo effects of IL-2 and IL-7 on adoptively transferred T-cells. Vaccine. 1997;15:561-563.
44. Pavletic Z, Benyunes MC, Thompson JA, et al. Induction by interleukin-7 of lymphokine-activated killer activity in lymphocytes from autologous and syngeneic marrow transplant recipients before and after systemic interleukin-2 therapy. Exp Hematol. 1993;21:1371-1378.
45. Kondo M, Nonomura N, Miki T, et al. Enhancement of interleukin-2-induced lymphokine-activated killer activity by interleukin-7 against autologous human renal cell carcinoma. Oncology. 1998;55:588-593.
46. Alpdogan O, Schmalz C, Muriglan SJ, et al. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood. 2001;98:2256-2265.
47. Sinha ML, Fry TJ, Fowler DH, Miller G, Mackall CL. Interleukin-7 worsens graft-vs-host disease. Blood. 2002;100:2642-2649.
48. Pflanz S, Timans JC, Cheung J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T-cells. Immunity. 2002;16:779-790.
49. Napolitano LA, Grant RM, Deeks SG, et al. Increased production of IL-7 accompanies HIV-1 mediated T-cell depletion: implications for T-cell homeostasis. Nat Med. 2001;7:73-79.
50. Mombaerts P, lacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1 deficient mice have no mature B and T lymphocytes. Cell. 1992;68:869-877.
51. Van Ewijk W, Holländer G, Terhorst C, Wang B. Stepwise development of thymic microenvironments in vivo is regulated by thymocyte subsets. Development. 2000;127:1583-1591.
52. Okamoto Y, Douek DC, McFarland RD, Koup RA. Effects of exogenous interleukin-7 on human thymus function. Blood. 2002;99:2851-2858.
53. Pido-Lopez J, Imami N, Andrew D, Aspinall R. Molecular quantitation of thymic output in mice and the effect of IL-7. Eur J Immunol. 2002;32: 2827-2836.
54. Rodewald HR, Ogawa M, Haller C, Waskow C, DiSanto JP. Pro-thymocyte expansion by c-kit and the common cytokine receptor γ-chain is essential for repertoire formation. Immunity. 1997;6: 265-272.
55. + thymic epithelial cells. Nat Immunol. 2002;3:635-642.
56. Bennett AR, Farley A, Blair NF, Gordon J, Sharp L, Blackburn CC. Identification and characterization of thymic epithelial progenitor cells. Immunity. 2002;16:803-814.